Stella Pharma Corp. Hits Day High with 10.86% Surge in Stock Price

Stella Pharma Corp. has experienced a significant uptick in its stock performance, gaining 10.86% on April 7, 2026. The stock reached an intraday high of JPY 670.00, marking a notable moment in its trading activity. This surge stands in contrast to the Japan Nikkei 225, which saw a minimal increase of just 0.03% on the same day. Over the past month, Stella Pharma has shown a remarkable 36.81% increase, significantly outperforming the Nikkei 225, which declined by 3.94%. The company's one-year performance is particularly impressive, with a return of 124.04%, compared to the Nikkei's 71.6%. Year-to-date, Stella Pharma has surged by 216.75%, highlighting its strong performance relative to the broader market. Despite these positive short-term trends, the company faces challenges, including a low return on equity and negative EBITDA. The market capitalization stands at JPY 8,066 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology industry. Investors may want to consider these factors as they evaluate the stock's current position in the market.